The Procter & Gamble Company Q4 2026 Earnings Recap

Shares of Procter & Gamble declined 3.3% following earnings as investors reacted negatively to lower core EPS and margin compression driven by cost pressures and trade dynamics, despite stable organic sales growth.

Key Takeaways

• Core EPS declined 3% year-over-year to $1.43 in Q4, with a 5% decrease on a currency-neutral basis.
• Core operating margin contracted 130 basis points in the quarter, despite a 460 basis point productivity improvement.
• Organic sales were essentially flat in Q4, with modest 1% growth adjusted for restructuring impacts and 2% growth excluding inventory timing effects.
• U.S. organic sales fell 1% amid trade-related sell-in and sell-out mismatches and retailer inventory reductions following shifts like the Amazon Prime Day timing.
• Gross margin remained roughly flat year-over-year, but significant input cost spikes in energy, transportation, and materials weighed on profitability.